Header Logo

Connection

Susanna Ulahannan to Bevacizumab

This is a "connection" page, showing publications Susanna Ulahannan has written about Bevacizumab.
Connection Strength

0.089
  1. Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer. Cancer Invest. 2011 May; 29(4):325-37.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.